This company listing is no longer active
Salud financiera de hoja de balance de TCR2 Therapeutics
Salud financiera controles de criterios 6/6
TCR2 Therapeutics has a total shareholder equity of $226.3M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $308.0M and $81.8M respectively.
Información clave
0%
Ratio deuda-patrimonio
US$0
Deuda
Ratio de cobertura de intereses | n/a |
Efectivo | US$206.24m |
Patrimonio | US$226.26m |
Total pasivo | US$81.78m |
Activos totales | US$308.04m |
Actualizaciones recientes sobre salud financiera
No hay actualizaciones
Recent updates
Análisis de la situación financiera
Pasivos a corto plazo: 2K7's short term assets ($215.8M) exceed its short term liabilities ($38.6M).
Pasivo a largo plazo: 2K7's short term assets ($215.8M) exceed its long term liabilities ($43.2M).
Historial y análisis de deuda-patrimonio
Nivel de deuda: 2K7 is debt free.
Reducción de la deuda: 2K7 has not had any debt for past 5 years.
Hoja de balance
Análisis de cash runway
En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.
Cash runway estable: 2K7 has sufficient cash runway for more than a year based on its current free cash flow.
Pronóstico de cash runway: 2K7 has sufficient cash runway for 1.5 years if free cash flow continues to reduce at historical rates of 36.5% each year.